Aragen receives SBTi approval for its greenhouse gas emission reduction targets
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
Paves the way for next-gen ultra-precise gas sensing
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington
Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results
The company also reported significant progress toward its internally defined Sustainable Development Goals
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
This global affiliation marks a critical step in the company’s mission to create long-term value through ethical practices, scientific innovation, and inclusive healthcare delivery
Subscribe To Our Newsletter & Stay Updated